Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
35.99
-0.16 (-0.44%)
Feb 21, 2025, 4:00 PM EST - Market closed
Bright Minds Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Market Capitalization | 254 | 5 | 6 | 20 | 85 | - | |
| Market Cap Growth | 3397.75% | -18.98% | -70.74% | -75.79% | - | - | |
| Enterprise Value | 213 | 0 | 0 | 14 | 67 | - | |
| Last Close Price | 35.99 | 1.17 | 1.60 | 6.15 | 35.71 | - | |
| PB Ratio | 6.31 | 1.19 | 1.23 | 2.67 | 5.51 | - | |
| P/TBV Ratio | 6.24 | 1.19 | 1.23 | 2.67 | 5.51 | - | |
| Debt / Equity Ratio | 0.00 | 0.02 | 0.01 | 0.01 | - | - | |
| Quick Ratio | 125.59 | 10.91 | 24.16 | 8.00 | 31.12 | 5.30 | |
| Current Ratio | 126.15 | 11.32 | 24.26 | 8.11 | 31.38 | 5.82 | |
| Return on Equity (ROE) | -3.35% | -46.18% | -86.02% | -99.95% | -85.94% | -124.04% | |
| Return on Assets (ROA) | -4.93% | -25.19% | -47.45% | -57.32% | -51.52% | -61.70% | |
| Return on Capital (ROIC) | -5.02% | -26.53% | -51.86% | -61.21% | -53.54% | -76.64% | |
| Earnings Yield | -0.29% | -42.70% | -90.90% | -53.20% | -8.09% | - | |
| FCF Yield | -0.70% | -28.20% | -86.61% | -48.30% | -6.84% | - | |
| Buyback Yield / Dilution | -29.26% | -15.87% | -50.57% | -37.64% | -148.42% | -74.24% | |
| Total Shareholder Return | -29.26% | -15.87% | -50.57% | -37.64% | -148.42% | -74.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.